SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,944.28 -12.99
( -0.02%)

Global Indices

Nasdaq

53,227.35 -353.64
(-0.66%)

Dow Jones

7,711.10 -21.66
(-0.28%)

Hang Seng

66,431.13 119.20
(0.18%)

Nikkei 225

10,792.77 -31.49
(-0.29%)

Forex

USD-INR

95.47 -0.01
(-0.01%)

EUR-INR

110.57 -0.67
(-0.60%)

GBP-INR

129.19 -0.55
(-0.42%)

JPY-INR

0.60 0.00
(-0.48%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Bliss GVS Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

506197

INE416D01022

108.7023673

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

BLISSGVS

56.5

6550.8

EPS(TTM)

Face Value()

Div & Yield %

10.91

0.16

Back

Castrol India standalone net profit rises 3.74% in the March 2026 quarter

Apr 28,2026

Net profit of Castrol India rose 3.74% to Rs 242.18 crore in the quarter ended March 2026 as against Rs 233.46 crore during the previous quarter ended March 2025. Sales rose 8.67% to Rs 1545.24 crore in the quarter ended March 2026 as against Rs 1422.00 crore during the previous quarter ended March 2025.

Particulars	Quarter Ended
	Mar. 2026	Mar. 2025	% Var.
Sales	1545.24	1422.00	9
OPM %	21.31	21.61	-
PBDT	350.78	337.27	4
PBT	323.11	312.72	3
NP	242.18	233.46	4

76,944.28 -12.99 ( -0.02%)

53,227.35 -353.64 (-0.66%)

7,711.10 -21.66 (-0.28%)

66,431.13 119.20 (0.18%)

10,792.77 -31.49 (-0.29%)

95.47 -0.01 (-0.01%)

110.57 -0.67 (-0.60%)

129.19 -0.55 (-0.42%)

0.60 0.00 (-0.48%)